RENAISSANCE TECHNOLOGIES LLC
Position in BHC — Bausch Health Companies Inc.
CIK 1037389
NEW YORK, NY
Position in BHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,530,026
-$1,979,142 QoQ
Shares Held
1,324,549
-15.9% QoQ
Ownership
0.354%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 220 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. BHC ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in BHC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,530,026 | 1,324,549 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,509,168 | 1,575,772 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,953,727 | 1,432,191 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,641,134 | 1,184,672 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,068,146 | 760,983 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,884,930 | 909,572 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,991,086 | 495,172 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $217,056 | 26,600 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $165,516 | 15,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,127,617 | 265,289 | Shares | Sole | 2024-02-13 | |
| 2023-03-31 | $9,195,840 | 1,135,289 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $4,548,199 | 544,043 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $26,364,078 | 1,153,789 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,175,150 | 115,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $648,905 | 23,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $21,151,125 | 721,389 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $23,149,886 | 729,360 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $41,395,328 | 1,990,160 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $56,669,096 | 3,646,660 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $151,464,044 | 8,281,249 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $207,736,409 | 13,402,349 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||